Mankind Pharma Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mankind Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014099
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mankind Pharma Ltd (MPL) is a healthcare products provider that manufactures and markets prescriptions medicines, over-the-counter and FMCG products. The company offers tablets, infusions, capsules, injections, dry syrups and drops, among others. Its products are used in therapeutic areas of anti infective, pain management and analgesics; GI and alimentary; anti allergy, nutritionals, CNS, women health, anti diabetic, cardiovascular, dermatology, ophthalmology, dental and urology. MPL carries research activities in the fields of novel drug delivery systems, new molecule research, and API development. The company markets its products in India and abroad. MPL is headquartered in New Delhi, India.

Mankind Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mankind Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Mankind Pharma May Sell 15% Stake in Itself 11
Cairnhill CIPEF and Cairnhill CGPE to Acquire 11% Stake in Mankind Pharma 12
Capital International Acquires 11% Stake in Mankind Pharma from ChrysCapital for USD215 Million 13
Mankind Pharma Ltd – Key Competitors 14
Mankind Pharma Ltd – Key Employees 15
Mankind Pharma Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Jan 21, 2016: Mankind Pharma To Invest INR3 Billion In US Manufacturing Plant 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mankind Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mankind Pharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Mankind Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mankind Pharma May Sell 15% Stake in Itself 11
Cairnhill CIPEF and Cairnhill CGPE to Acquire 11% Stake in Mankind Pharma 12
Capital International Acquires 11% Stake in Mankind Pharma from ChrysCapital for USD215 Million 13
Mankind Pharma Ltd, Key Competitors 14
Mankind Pharma Ltd, Key Employees 15
Mankind Pharma Ltd, Subsidiaries 16

★海外企業調査レポート[Mankind Pharma Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • South Broward Hospital District:企業の戦略的SWOT分析
    South Broward Hospital District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Medicure Inc (MPH):企業の財務・戦略的SWOT分析
    Summary Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company offers products such as Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndro …
  • Ion Beam Applications SA (IBAB):医療機器:M&Aディール及び事業提携情報
    Summary Ion Beam Applications SA (IBA) develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses its activities on proton therapy solut …
  • Jungbunzlauer Suisse AG:企業の戦略・SWOT・財務情報
    Jungbunzlauer Suisse AG - Strategy, SWOT and Corporate Finance Report Summary Jungbunzlauer Suisse AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Informa plc:企業の戦略・SWOT・財務分析
    Informa plc - Strategy, SWOT and Corporate Finance Report Summary Informa plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Aptinyx Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aptinyx Inc (Aptinyx), formerly Enarex, Inc., is a biopharmaceutical company which focuses on the discovery and development of novel therapies for the treatment of brain and nervous system disorders. The company has a robust chemistry library with small molecule compounds which are designed …
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Adaptimmune Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Adaptimmune Ltd (Adaptimmune) a subsidiary of Adaptimmune Therapeutics plc operates as a clinical trials and pipeline company. The company engaged in developing T-cell receptors for T-cell therapy and SPEAR TCR therapies. Its clinical trials include synovial sarcoma trial, multiple myeloma t …
  • ContraFect Corp (CFRX):企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …
  • Fortis Inc.:企業の戦略・SWOT・財務分析
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Robinson Helicopter Company, Inc.:企業の戦略・SWOT・財務分析
    Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Huawei Technologies Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Huawei Technologies Co., Ltd. (Huawei), a subsidiary of Huawei Investment & Holding Co., Ltd, is an information and communication technology company. The company’s product portfolio includes mobile, broadband, core network, transmission network, and data communication products, besides value …
  • Rentokil Initial plc:企業の戦略・SWOT・財務分析
    Rentokil Initial plc - Strategy, SWOT and Corporate Finance Report Summary Rentokil Initial plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Teijin Ltd (3401)-医療機器分野:企業M&A・提携分析
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Ping An Insurance (Group) Company of China, Ltd.:企業のM&A・事業提携・投資動向
    Ping An Insurance (Group) Company of China, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ping An Insurance (Group) Company of China, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Bin Qasim Ltd (FFBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Pacific Scientific Energetic Materials Company:企業の戦略・SWOT・財務情報
    Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report Summary Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Outset Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Outset Medical, Inc., (Outset Medical) is a medical technology company engaged in developing hemodialysis system for the treatment of kidney diseases. The company offers Tablo Hemodialysis machine that makes water clean, produces dialysate, takes blood pressure, and delivers medication for p …
  • Southwestern Electric Power Co:企業の発電所・SWOT分析2018
    Southwestern Electric Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Wilton Resources Inc (WIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Wilton Resources Inc (Wilton Resources) is an exploration and development company that develops oil and gas reserves. The company offers exploration of underdeveloped conventional and unconventional resources with prime focus on African continent. It operates in the process of acquiring oil …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆